Insights on the Allergy Immunotherapies Global Market to 2027 - by Treatment Type, Allergy Type, Distribution Channel and Region

DUBLIN, March 8, 2022 /PRNewswire/ -- The "Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The global allergy immunotherapies market reached a value of US$ 2.56 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 4.63 Billion by 2027, exhibiting a CAGR of 10.2% during 2022-2027. Keeping in mind the uncertainties of COVID-19, they are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor

Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites. It alters the immune system's response by gradually increasing the doses of the allergen. Before the treatment begins, an allergist and patient analyze triggering factors for allergy symptoms, which may involve skin and blood tests to confirm the allergens. Allergy immunotherapy helps in reducing inflammation, offering long-term impact, increasing immunological tolerance, changing the course of the disease and improving the quality of the patient's life

In recent years, there has been a rise in the prevalence of allergies around the world on account of various environmental and lifestyle factors that influence the functioning of the immune system. With the growing awareness of allergy immunotherapies, elevating income levels and increasing healthcare expenditure, the demand for sophisticated and long-term treatment options is increasing, which in turn is stimulating the growth of the market. It is further supported by the rising clinical research and development budget owing to several initiatives undertaken by both governmental and non-governmental organizations around the world.

Further, with the latest drug development technologies, pharmaceutical firms have created more efficient immunotherapies for treating an array of allergies successfully. This, coupled with advancements in the field of allergy diagnostics, is catalyzing the global allergy immunotherapies market growth.

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Group, DBV Technologies, Merck Group, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, and Biomay AG, etc

Key Question Answered in this Report
1. What was the size of the global allergy immunotherapies market in 2021?
2. What is the expected growth rate of the global allergy immunotherapies market during 2022- 2027?
3. What are the key factors driving the global allergy immunotherapies market?
4. What has been the impact of COVID-19 on the global allergy immunotherapies market?
5. What is the breakup of the global allergy immunotherapies market based on the treatment type?
6. What is the breakup of the global allergy immunotherapies market based on the allergy type?
7. What is the breakup of the global allergy immunotherapies market based on the distribution channel?
8. What are the key regions in the global allergy immunotherapies market?
9. Who are the key players/companies in the global allergy immunotherapies market?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Allergy Immunotherapies Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Treatment Type
5.5 Market Breakup by Allergy Type
5.6 Market Breakup by Distribution Channel
5.7 Market Breakup by Region
5.8 Market Forecast

6 Market Breakup by Treatment Type
6.1 Subcutaneous Immunotherapy (SCIT)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Sublingual Immunotherapy (SLIT)
6.2.1 Market Trends
6.2.2 Market Forecast

7 Market Breakup by Allergy Type
7.1 Allergic Rhinitis
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Asthma
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Food Allergy
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Venom Allergy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast

8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacy
8.3.1 Market Trends
8.3.2 Market Forecast

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis
13.1 Price Indicators
13.2 Price Structure
13.3 Margin Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 ALK-Abello A/S
14.3.2 Allergy Therapeutics
14.3.3 Stallergenes Greer
14.3.4 HAL Allergy Group
14.3.5 DBV Technologies
14.3.6 Merck Group
14.3.7 Aimmune Therapeutics
14.3.8 Circassia Pharmaceuticals
14.3.9 Anergis SA
14.3.10 Biomay AG

For more information about this report visit https://www.researchandmarkets.com/r/5nm977

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets